Clinical Trial Update: Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing escitalopram to risperidone for behavioral and psychological symptoms in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lexapro (escitalopram)
• Risperdal (risperidone)

Snippet

Sponsor: Abarbanel Mental Health Center | Conditions: Agitation, Psychosis | Phase 4 | Status: COMPLETED